Published in:
03-01-2021 | Tuberculosis | Letter to the Editor
Development of high signal intensity within the globus pallidus and dentate nucleus following multiple administrations of gadoterate meglumine in a patient with neurotuberculosis
Authors:
Bahar Cankaya, Yasemin Ogul, Hayri Ogul, Mecit Kantarci
Published in:
Acta Neurologica Belgica
|
Issue 3/2022
Login to get access
Excerpt
Since 1988, when gadolinium-based contrast agents (GBCAs) have been approved by the Food and Drug Administration (FDA). At that time, those have been considered extremely safe pharmaceutical agents [
1]. However, in the early 2000s, research has shown that unstable forms of GBCAs cause nephrogenic systemic fibrosis in patients with poor renal function [
2]. This has led to the questioning of the safety of GBCAs, and over time, it has been proven that linear GBCAs accumulate in deep cerebellar nuclei depending on concentration [
3,
4]. …